Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $806859.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 53.92% year-over-year to $806859.0, compared with a TTM value of $806859.0 through Dec 2025, down 53.92%, and an annual FY2025 reading of $1.3 million, down 40.81% over the prior year.
  • Other Non-Current Liabilities was $806859.0 for Q4 2025 at Neuroone Medical Technologies, down from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.1 million in Q3 2024 and bottomed at $83333.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 3 years is $1.2 million, with a median of $1.3 million recorded in 2025.
  • Peak annual rise in Other Non-Current Liabilities hit 40.81% in 2025, while the deepest fall reached 53.92% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $83333.0 in 2021, then soared by 2001.05% to $1.8 million in 2024, then plummeted by 53.92% to $806859.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NMTC at $806859.0 in Q4 2025, $1.3 million in Q3 2025, and $1.0 million in Q2 2025.